Upcoming investor conferences

Innate Pharma SA (the “Company” - Euronext Paris: FR0010331421 – IPH), the innate immunity company developing first-in-class therapeutic antibodies for cancer and inflammatory diseases, today announced that it will be present at the following investor events during the second half of 2015:

• Goldman Sachs Biotech Day – London, September 11, 2015;
• Bank of America Merrill Lynch Global Healthcare Conference – London, September 16 - 18, 2015;
• Natixis Immuno-Oncology event – London, September 22, 2015;
• Credit Suisse European tour – London, September 22, 2015;
• Leerink inaugural Immuno-Oncology roundtable conference – New York, October 1, 2015;
• Citi Pan European Healthcare Investor Trip – Paris, October 2, 2015;
• Large & Midcap Event – Paris, October 6 & 7, 2015;
• Portzamparc Biotech Conference – Paris, Octobre 14, 2015;
• Société Générale CIB Conference Healthcare & Biotechnology – Paris, November 5, 2015;
• Morgan Stanley “Meet the Biotechs” day – Paris, November 9, 2015;
• Citi Global Healthcare Conference – New-York, November 4 & 5, 2015;
• Jefferies Global Healthcare Conference – London, November 18 & 19, 2015.

*****
Half-year results:
Innate Pharma will publish its half-year results on September 17, 2015 before French market opens.
A conference call will take place on the same day at 2:30pm.
Dial-in numbers will be available on Innate Pharma’s website homepage as well as on the results press release.
*****